Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Business Angels des Grandes Ecoles

Investor type Angel Group

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 13
Average round size
info
The average size of a deal this fund participated in
$2M
Portfolio companies 11
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.15
Key employees 4
Stages of investment
Seed

Areas of investment

  • Health Care
  • Medical Device
  • Biotechnology
  • Medical
  • Artificial Intelligence

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Business Angels des Grandes Ecoles:
Typical Co-investors
Business Angels des Grandes Ecoles is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Business Angels des Grandes Ecoles:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Axivate Capital Amsterdam, Noord-Holland, The Netherlands
Changzhou Chang Jin Chuangye Touzi Youxian Gongsi Changzhou, China, Zhejiang
Company Ventures New York, New York, United States
General Motors Investment Management New York, New York, United States
IBG Innovationsfonds -
Illinois Finance Authority Chicago, Illinois, United States
Invictus Capital Cayman Islands, Midland
Jinshi Investment Beijing, Beijing, China
Kero Development Partners Cheshire, Chester, United Kingdom
Maipu Communication Chengdu, China, Sichuan
Moodoos Investments California, San Diego, United States
Pfm Capital Canada, Regina, Saskatchewan
Scout Analytics Issaquah, United States, Washington
Sprindrift Equities New York, New York, United States
Suoni Zhongguo Zhixing Jijin -
Techno Pacific Assets -
University of Bristol Bristol, England, United Kingdom
Woke Chuanmei China, Guangdong, Guangzhou
Zhongchanng Data -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

MOTEN Technologies

Health Care
Innovation Management
Medical
Test and Measurement
$1M13 Oct 2022 Puteaux, Ile-de-France, France

WATTPARK

$1M15 Nov 2021 Centre, Ile-de-France, France

PEP-Therapy

Biotechnology
Medical
Therapeutics
$1M19 Jul 2021 Évry-Courcouronnes, Ile-de-France, France

PEP-Therapy

Biotechnology
Medical
Therapeutics
$3M22 Apr 2021 Évry-Courcouronnes, Ile-de-France, France

Imageens

Medical Device
$1M15 Apr 2021 Paris, Ile-de-France, France

OncoDiag

Biotechnology
$2M15 Mar 2021 France, Auvergne-Rhône-Alpes, France

Wefight

Health Care
$2M29 Aug 2019 Paris, Ile-de-France, France

Trainme

Communities
Education
Fitness
Sports
01 Mar 2019 Paris, Ile-de-France, France

Cardiawave

Collaboration
Health Care
Medical Device
$8M27 Sep 2018 Paris, Ile-de-France, France
News
Imageens Raises €1.2M in Seed Financing

– Imageens, a Paris, France-based medical Artificial Intelligence (AI) startup developing software solutions for the analysis of medical images, raised €1.2M in seed financing.
– The round was led by Anaxago, with participation from BADGE (Business Angels des Grandes Ecoles), COALESCENCE, and existing investors.

OncoDiag Raises €2.5M in Series A Funding

– OncoDiag, a Miserey, near Evreux, France-based company specializing in the development of diagnostic tests for the early detection of cancer, raised €2.5m ($3M) in Series A funding.
– The funding was led by Angels Santé, Business Angels des Grandes Ecoles (BADGE), Normandie Business Angels (NBA), Paris Business Angels (PBA), and the Société de Financement de l’Innovation Numérique en Essonne (SFINE).
– The Region of Normandy also contributed to this round of financing and will be joining the pool of investors, via Normandie Participations.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Business Angels des Grandes Ecoles?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: